ML385

629 Cited Publications
Avis client

Based on 629 publication(s) in Google Scholar

ML385 is a potent and selective Nrf2 inhibitor with an IC50 of 1.9 μM. ML385 directly binds to the Neh1 domain of NRF2, interferes with the binding of the MAFG-NRF2 protein complex to the antioxidant response element (ARE) DNA sequence, thereby blocking the expression of downstream target genes of NRF2. ML385 can be used in studies related to adult T-cell leukemia, breast cancer, myocardial ischemia/reperfusion injury, non-small cell lung cancer, esophageal squamous cell carcinoma, head and neck squamous cell carcinoma, and lung squamous cell carcinoma.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 99.84%
  • CAS No.: 846557-71-9
  • Formule: C29H25N3O4S
  • Masse moléculaire:511.59
  • Stockage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 2 years , -20°C, 1 year
  • Activité biologique
  • Chemical Information
  • Solvant et solubilité
  • Pureté et documentation
  • Références
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) ML385

More
Customer Validation & Images
WBIHCIFRT-PCR
  • RT-PCR
  • WB
  • WB
  • IF
  • RT-PCR
  • WB
  • WB
  • WB
  • IHC
  • WB
  • WB
  • WB

Voir tous les produits spécifiques à Isoform mTOR

More
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00